Cargando…

A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients

BACKGROUND: US hematopoietic cell transplantation (HCT) recipients have a low prevalence of latent tuberculosis infection (LTBI), but if latently infected they are at risk for progression to active tuberculosis. At our center, all HCT recipients underwent LTBI testing pretransplant by tuberculin ski...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosa-Moreno, Andrea, Narita, Masahiro, Spitters, Christopher, Swetky, Michelle, Podczervinski, Sara, Lind, Margaret L, Holmberg, Leona, Liu, Catherine, Edelstein, Raleigh, Pergam, Steven A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348235/ https://www.ncbi.nlm.nih.gov/pubmed/32671130 http://dx.doi.org/10.1093/ofid/ofaa224

Ejemplares similares

Predictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections
por: Lind, Margaret L, et al.
Publicado: (2020)

Evaluating risk factors for Clostridiumdifficile infection in adult and pediatric hematopoietic cell transplant recipients
por: Boyle, Nicole M., et al.
Publicado: (2015)

Screening for Latent Tuberculosis Infection in Solid Organ Transplant Recipients to Predict Active Disease: A Systematic Review and Meta-Analysis of Diagnostic Studies
por: Yahav, Dafna, et al.
Publicado: (2023)

Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents
por: Miller, Matthew A, et al.
Publicado: (2020)

Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome Evolution
por: Ogimi, Chikara, et al.
Publicado: (2017)

Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review
por: Snyder, Matthew, et al.
Publicado: (2017)

Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study
por: Schuster, Mindy G., et al.
Publicado: (2017)

Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma E, et al.
Publicado: (2019)

Microbiology and Risk Factors for Hospital-Associated Bloodstream Infections Among Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Akinboyo, Ibukunoluwa C, et al.
Publicado: (2020)

Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
por: Roth, Romain Samuel, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients
por: Kokogho, Afoke, et al.
Publicado: (2023)

SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
por: Lindsay, Julian, et al.
Publicado: (2021)

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, I P, et al.
Publicado: (2018)

Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies
por: Ogimi, Chikara, et al.
Publicado: (2017)

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer
por: Boeckh, Michael J, et al.
Publicado: (2020)

Risk Factors for CMV Viremia and Treatment-Associated Adverse Events Among Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Heston, Sarah M, et al.
Publicado: (2021)

Prior Screening for Latent Tuberculosis Among Patients Diagnosed With Tuberculosis Disease: Missed Opportunities?
por: Fischer, Heidi, et al.
Publicado: (2023)

Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease
por: Dioverti, M Veronica, et al.
Publicado: (2017)

Stratification of Latent Mycobacterium tuberculosis Infection by Cellular Immune Profiling
por: Halliday, Alice, et al.
Publicado: (2017)

Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection
por: Feria, Manuel G, et al.
Publicado: (2022)

Detection of Adeno-Associated Virus Viremia in Hematopoietic Cell Transplant Recipients
por: Heugel, Judson, et al.
Publicado: (2011)

Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
por: Lee, Meng-Rui, et al.
Publicado: (2017)

Tuberculosis in Hematopoietic Stem Cell Transplant Recipients
por: Ramos, Jéssica Fernandes, et al.
Publicado: (2013)

Evaluation of latent tuberculosis infection in liver transplant recipients
por: Ahmadinejad, Zahra, et al.
Publicado: (2021)

Supplemental Oxygen–Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus
por: Waghmare, Alpana, et al.
Publicado: (2017)

Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis
por: Uzorka, Jonathan W, et al.
Publicado: (2019)

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Ariza-Heredia, Ella J, et al.
Publicado: (2023)

Latent tuberculosis in adult hematopoietic stem cell transplantation recipients: Clinical experience from a previously endemic population
por: Mert, Duygu, et al.
Publicado: (2022)

Routine Donor and Recipient Screening for Mycoplasma hominis and Ureaplasma Species in Lung Transplant Recipients
por: Vijayvargiya, Prakhar, et al.
Publicado: (2022)

Real-World Outcomes Associated With Letermovir Use for Cytomegalovirus Primary Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Systematic Review and Meta-analysis of Observational Studies
por: Vyas, Ami, et al.
Publicado: (2022)

Are hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center
por: Lind, Margaret L., et al.
Publicado: (2021)

Unintended Consequences of Pre-transplant VRE Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients
por: Stohs, Erica, et al.
Publicado: (2017)

Latent Tuberculosis Infection Treatment Practices in Two Large Integrated Health Systems in California, 2009–2018
por: Bruxvoort, Katia J, et al.
Publicado: (2023)

Prevalence of latent Mycobacterium tuberculosis infection in renal transplant recipients
por: Maciel, Mônica Maria Moreira Delgado, et al.
Publicado: (2018)

Latent Tuberculosis Infection Status of Pregnant Women in Uganda Determined Using QuantiFERON TB Gold-Plus
por: Bongomin, Felix, et al.
Publicado: (2021)

663. Epidemiology and outcomes of recurrent C. difficile infection among hematopoietic cell transplant recipients
por: Sanchez, Eduardo, et al.
Publicado: (2023)

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
por: Kim, Yae-Jean, et al.
Publicado: (2014)

Influenza Viral RNA Detection in Blood as a Marker to Predict Disease Severity in Hematopoietic Cell Transplant Recipients
por: Choi, Su-Mi, et al.
Publicado: (2012)

T-Cell Immunophenotyping Distinguishes Active From Latent Tuberculosis
por: Pollock, Katrina M., et al.
Publicado: (2013)

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
por: Waghmare, Alpana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5he9b8493sq9cv4rbspv5m8bfo